International Forum on Rectal Cancer

Dear Colleagues, Welcome to FICARE 2024!

It is our pleasure to announce that from November 14th to 15th São Paulo will be stage of the largest forum on Rectal Cancer in Latin America. FICARE 2024 will take place in the WTC Sheraton Hotel in São Paulo, Brazil!

Once again we are bringing together a stellar group of faculty in a very intense 2-day meeting to cover the latest and the most exciting of rectal cancer data worldwide!

The very best knowledge creators worldwide will debate, here, on TNT advancements and how to select patients for each strategy. Is there still role for straight forward surgery in the post-pandemic era? What about local excision for rectal cancer, is it the past or is it the future? All together in this very exciting meeting. From improvements in surgical technique, to refined selection for organ preservation. From enhanced radiological staging, to personalized onco-radiation therapies. You cannot miss it.

Get ready for hot debates among outstanding world specialists in each topic.

We will have a blend of celebrities of rectal cancer such as Debora Schrag, Gina Brown, Roel Hompes; Quentin Denost, Emmanouil Fokas, Geerard Beets, Antonino Spinelli, Julio Garcia Aguilar, Andrea Cercek, Simon Bach, Sergey Efetov, Sun Myint, Gyuseog Choi and many others, the sessions will be extremely interesting.

Get ready for days of intense scientific activity, mixed with pleasant social activities and the opportunity to see friends and international guests again.

Welcome and enjoy!

Angelita Habr-Gama
President

Rodrigo Oliva Perez
General Secretary

FICARE 2024

Don't miss the World's Largest Rectal Cancer Forum

VENUE

hotel Sheraton WTC Hotel

Address

WTC Sheraton São Paulo Hotel
Av. das Nações Unidas, nº 12.559
Brooklin Novo
São Paulo – SP

International Faculty

  • Andrea Cercek

  • Carl Brown

  • Debora Schrag

  • Emmanouil Fokas

  • Gina Brown

  • GyuSeog Choi

  • Josh Smith

  • Julio Garcia Aguilar

  • Laura Fernandez

  • Quentin Denost

  • Patricia Tejedor

  • Roel Hompes

  • Sergey Efetov

  • Sun Myint

  • Thierry Conroy

  • Tsuyoshi Konishi

PROGRAM

Is Magnetic resonance useful to select patients for local treatment in early rectal cancer?
Gina Brown

When transanal Local excision for pT1 ALONE is enough? Preliminary data from the TESAR trial & intermuscular dissection.
Roel Hompes

Chemotherapy and Local Excision for early rectal cancers? The NEO trial.
Carl Brown

GRECCAR 12 – The use of neoadjuvant Folfirinox for organ-preservation.
Quentin Denost

Local excision after nCRT or TNT? When and how?
Julio Garcia Aguilar

Discussion

Intermuscular Local excision for early rectal cancer.
Roel Hompes

Completion TME after initial local excision – is it a nightmare?
Quentin Denost

Discussion

10:00

Total Neoadjuvant Therapy for the achievement of a cCR?
Guilherme Pagin São Julião

Short-course or Long-course when WW is the goal? The German trial and current data available.
Emmanouil Fokas

Long-course RT + Contact radiation leads nearly 90% organ preservation – Why anything else?
Sun Myint

Isn’t TME (without RT or chemotherapy) a better option?
Roel Hompes

Discussion

The anatomical landmarks and challenges for each compartment in pelvic exenteration.
Gina Brown

Level of sacral resection – what are the limits?
Quentin Denost

The recurrent lateral pelvic node long after TME.
Tsuyoshi Konishi

Discussion

PRODIGE – Why FOLFIRINOX should be the new normal in all locally advanced rectal cancer.
Thierry Conroy

PROSPECT – Can we avoid radiation? When and for whom can we eliminate RT?
Debora Schrag

OPRA - Is organ-preservation main-stream now? What still needs to be done? Lessons learned from the OPRA trial.
Julio Garcia-Aguilar

Current status of MSI rectal cancer managed by immunotherapy – Where are we at?
Andrea Cercek

Elderly and Frail patients with locally advanced disease – How to balance treatment morbidity.
Emmanouil Fokas

Discussion

Emmanouil Fokas

Debora Schrag

Julio Garcia-Aguilar

Thierry Conroy

Sun Myint

Gina Brown

Roel Hompes

Andrea Cercek

Radiological Assessment - How nodal staging became less relevant than other radiological features for the decision management in rectal cancer?
Gina Brown

MR quality in rectal cancer – How heterogenous is the quality of MR and how it impacts decision management?
Cinthia Ortega

How tridimensional vascular reconstruction may help surgeon plan/perform rectal cancer surgery.
Patricia Tejedor

What about lateral pelvic nodes? Pre or post treatment findings to consider lateral node dissection?
Tsuyoshi Konishi

Discussion

Retroperitonial approach for the left colon – When you do not want to get into the abdomen.
Sergey Efetov

Lateral node dissection – the role of ICG.
Gyu-Seog Choi

What is a proper D3 dissection in upper rectal cancer.
Sergey Efetov

Robotic TME – How I do it – step by step.
Laura Fernandez

Combined TME & prostatectomy with the use of robot.
Gyu-Seog Choi

Discussion

The “perfect” lateral node dissection with the robot – Tips and tricks.
Gyu-Seog Choi

Lateral node in the setting of a complete clinical response.
Guilherme Pagin São Julião

Lateral node dissection without preoperative treatment – Is there a role? What to do with a patient with a 7mm node in the absence of other high-risk factors?
Tsuyoshi Konishi

Discussion

10:00

When double-stapling is the preferred strategy and new stapling alternatives.
Bruna Vailati

Transrectal transection and single-stapled anastomosis x Pull-through – Choosing one or the other?
Quentin Denost

Diversion or no diversion – Who should not be diverted and why?
Roel Hompes

Why ICG SHOULD be implemented into routine clinical practice.
Quentin Denost

Partial mesorectal excision – It’s all about the level of transection.
Roel Hompes

Discussion

What happens when mrEMVI+ become ymrEMVI-?
Gina Brown

What is a near-complete clinical response and how to deal with it?
Julio Garcia Aguilar

Local regrowths & the risk of distant metastasis – are we really at risk?
Laura Fernandez

Discussion

Case Discussion in locally advanced rectal cancer

5 cases and 5 initial treatment strategies

Moderator: Rodrigo Perez and Fernanda Mazzucato


Emmanouil Fokas

Debora Schrag

Julio Garcia-Aguilar

Thierry Conroy

Sun Myint

Gina Brown


1. T4aN0

2. T2/T3aN1 CRM clear / intersphincteric plane clear

3. T4bN0 candidate for APR

4. T2N0 CRM clear / interphincteric plane clear

5. EMVI+ CRM clear / intersphincteric plane clear

Robotic TME with synchronous liver metastasis resection.
Patricia Tejedor

Management of anastomotic leaks – aggressive transanal approach.
Roel Hompes

Minimally invasive para-aortic nodal dissection.
Tsuyoshi Konish

Intraoperative bleeding during lateral pelvic node dissection.
Tsuyoshi Konish

Minimally invasive Deloyers Procedure.
Leonardo Corbi

Discussion

Is there a place for Immunotherapy in MSS rectal cancer?
Andrea Cercek

Can we increase organ-preservation by intensifying treatment? JANUS trial.
Josh Smith

ctDNA in rectal cancer – what is the role in adjuvant chemotherapy decision management? Can we extrapolate data from colon cancer?
Andrea Cercek

Discussion

ADJOURN

HOTELS & TRAVEL

Hotels Ficare 2024

For more information, contact us via email: paradiso@paradisoturismo.com.br or phone: +55 (11) 3258-4722.

REGISTRATION

FICARE - TODOS OS DIREITOS RESERVADOS DEVELOPER BY PUBLITZ